Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000919574-23-005658
Filing Date
2023-10-13
Accepted
2023-10-13 09:59:54
Documents
1
Effectiveness Date
2023-10-13
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7921
  Complete submission text file 0000919574-23-005658.txt   9137
Mailing Address 3000 SAND HILL ROAD BUILDING 4, SUITE 250 MENLO PARK CA 94025
Business Address 94 SOLARIS AVENUE, CAMANA BAY PO BOX 1348 GRAND CAYMAN E9 KY1-1108 650-681-8482
Sofinnova BioEquities Enhanced Offshore Fund Ltd. (Filer) CIK: 0001949442 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-461677 | Film No.: 231324093